
Esketamine (Spravato; Janssen) CIII nasal spray is the first FDA-approved antidepressant medication that improves depressive symptoms with the first dose in adults with major depressive disorder.
Esketamine (Spravato; Janssen) CIII nasal spray is the first FDA-approved antidepressant medication that improves depressive symptoms with the first dose in adults with major depressive disorder.
Asking for better pay, hours, or work benefits can be intimidating for pharmacists, but these strategies can help you get the rewards you deserve.
The FDA approved a cannabidiol oral solution treatment (Epidiolex, Greenwich Biosciences) for seizures associated with tuberous sclerosis complex.
The American Society of Health-System Pharmacists (ASHP) announced plans to hold the 2020 Midyear Clinical Meeting in December as an all-virtual experience.
NACDS, APhA, NCPA, and others warn that overlooking DIR fee reform will be detrimental to pharmacy viability.
In an open letter, the American Pharmacist Association’s (APhA) Board of Trustees called for Americans to continue following public health guidelines.
Responding to growing interest by industry stakeholders, the agency has offered draft guidance outlining quality considerations and other practical recommendations for cannabis and cannabis-derived compounds.
The American Pharmacists Association (APhA) urged Congress to take immediate action to expand coronavirus disease 2019 (COVID-19) testing services by granting pharmacists temporary provider status.
A global pharmacy organization is aiming to help pharmacists expand their role in immunization via a new resource.
SingleCare’s second annual Pharmacy Awards honors pharmacists and pharmacy technicians, the COVID-19 pandemic’s unsung health care heroes.
The US government agreed to pay $1.95 billion for the first 100 million doses of Pfizer and BioNTech’s investigational candidate.
Prepare to counsel patients on microbiome-related products.
The Federal Vaccine Consultation Panel will allow industry leaders to share the questions, concerns, and needs of their constituencies related to the development and distribution planning of a COVID-19 vaccine.
The AZD1222 vaccine, made from a common cold virus present in chimpanzees, produced rapid neutralizing antibody levels against the SARS-CoV-2 virus.
The Oklahoma Board of Pharmacy fined CVS Health $125,000 after receiving multiple complaints about errors and overwhelmed staff members.
Once largely stigmatized, illicit substances are breaking into the field of pain management.
Pfizer and BioNTech SE announced that 2 of its most successful vaccine candidates received Fast Track designation from the FDA, opening the avenue for speedy development.
Enhanced pharmacy services such as home delivery, curbside services, and expanded personal patient outreach create opportunities to address social determinants of health during the pandemic.
Sandoz is collaborating with Civica Rx to provide critical injectable generic medicines to hospitals to help reduce supply shortages.
The American Cancer Society has updated its guidelines regarding the administration of the HPV vaccine.
A group of pharmacies and pharmacy organizations urged the Centers for Medicare & Medicaid Services to formally recognize and promote medical at home pharmacy services for long-term care.
NACDS is urging the Drug Enforcement Administration to make electronic prescriptions for controlled substances mandatory.
Kroger Health will start offering its COVID-19 Test Home Collection Kit with the guidance of a telehealth consultation.
The CDC has identified the pharmacy sector as a key partner in offering its lifestyle change-based program for patients with high risk for type 2 diabetes.
A collaboration between APhA and PTCB will help provide pharmacy technician credentialing in immunization delivery.
A Johns Hopkins research team has determined that tests are more likely to result in false negatives for the COVID-19 virus if taken too early in the course of infection.
In a new guidance, the FDA provides recommendations for those developing COVID-19 vaccines to ensure safety and efficacy.
An updated list of risk factors for severe COVID-19 expands possible underlying medical conditions and removes the age threshold.
Through the print publication and a growing digital footprint, Drug Topics® provides a dynamic range of content across the pharmaceutical spectrum.
Vaccine candidates for COVID-19 are going through clinical trials at a faster rate than for any other disease.